ANZU vs. MLSS, NTRB, APT, SPAI, RBOT, CLGN, COCH, LFWD, POAI, and NAOV
Should you be buying Anzu Special Acquisition Corp I stock or one of its competitors? The main competitors of Anzu Special Acquisition Corp I include Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), Vicarious Surgical (RBOT), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), ReWalk Robotics (LFWD), Predictive Oncology (POAI), and NanoVibronix (NAOV). These companies are all part of the "surgical appliances & supplies" industry.
Anzu Special Acquisition Corp I vs.
Anzu Special Acquisition Corp I (NASDAQ:ANZU) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.
Milestone Scientific has a consensus price target of $1.25, indicating a potential upside of 38.73%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Anzu Special Acquisition Corp I.
In the previous week, Milestone Scientific had 2 more articles in the media than Anzu Special Acquisition Corp I. MarketBeat recorded 2 mentions for Milestone Scientific and 0 mentions for Anzu Special Acquisition Corp I. Milestone Scientific's average media sentiment score of 0.81 beat Anzu Special Acquisition Corp I's score of 0.44 indicating that Milestone Scientific is being referred to more favorably in the news media.
27.3% of Anzu Special Acquisition Corp I shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 0.7% of Anzu Special Acquisition Corp I shares are owned by company insiders. Comparatively, 24.8% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Milestone Scientific received 2 more outperform votes than Anzu Special Acquisition Corp I when rated by MarketBeat users.
Anzu Special Acquisition Corp I has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500.
Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Milestone Scientific.
Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Anzu Special Acquisition Corp I's return on equity of -17.33% beat Milestone Scientific's return on equity.
Summary
Milestone Scientific beats Anzu Special Acquisition Corp I on 9 of the 14 factors compared between the two stocks.
Get Anzu Special Acquisition Corp I News Delivered to You Automatically
Sign up to receive the latest news and ratings for ANZU and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Anzu Special Acquisition Corp I Competitors List
Related Companies and Tools
This page (NASDAQ:ANZU) was last updated on 4/19/2025 by MarketBeat.com Staff
Buy ANZU Stock Free ANZU Stock Alerts